Company Introduction
is an IVD system service provider engaged in IVD, reagents, instruments and services
Hunan Yonghe-Sun Biotechnology Co.Ltd.
Hunan Yonghe-Sun Biotechnology Co.Ltd. ("the Company" or "Yonghe-Sun" for short), listed in NEEQ (TS 870853), is an IVD system service provider engaged in IVD, reagents, instruments and services. The Company is dedicated to being a system service provider in the IVD industry to provide precise medical services for human health. In addition, it is a POCT engineering technology research center, a national high-tech enterprise, a national "little giant" firm, an enterprise technology in Human Province and one of the six batch of intelligent manufacturing pilot enterprises in Changsha. Established in March 2006, the Company is headquartered in Changsha, Hunan. The Company has independently developed six core technologies, i.e. acridine ester direct chemiluminescence, HPLC, cyclophorase, latex-enhanced immunoturbidimetry (LETIA), colloidal gold and immunofluorescence, and built chemiluminiscence, glycohemoglobin, clinical biochemistry and POCT detection system and other diagnosis technology platforms, covering more than 150 associated products. Its marketing network covers the market across the country. In the IVD field, the Company has a high market influence.
In addition, the Company boasts 4,000m² garden-style plant, 100,000-grade clean workshops, brand new QC equipment and reference laboratories according to ISO17025 CNAS. In terms of QC, it has strictly followed the Good Manufacturing Practice (GMP). It has successively passed ISO13485 Medical Device Quality System Certification and External Quality Assessment (EQA) Program of National Center for Clinical Laboratories (NCCL).
Yonghe-Sun has undertaken "providing precise medical service for human health" as its mission, constantly pursued innovation and elaborately shaped the brand of "Yonghe-Sun". We will always adhere to our tenet "Innovate Technology to Take the Lead in the Health Undertaking" and our core value "Innovation, Strictness, Excellence & Dedication" to lay out our business in the IVD products industry.
2022
National "Little Giant" Firm approved
2021
2020
Immunofluorescence chromatography product line launched
2018
"Enterprise Technology Certification Center"; strategic cooperation with Hunan University and Hunan Testing Institute for Medical Devices
Enterprise Honor
Innovation in R&D
Since its establishment, Yonghe-Sun has been dedicated to the R&D and technical accumulation of IVD reagents and instruments. Every year, it maintains the R&D expenditure at minimum 15% of its operation revenue. For years of accumulation, it boasts six technology platforms, including acridinium ester chemiluminiscence, colloidal gold, immunofluorescence chromatography, cyclophorase, LETIA and HPLC, covering instruments, reagents, raw materials and so on. In addition, it has more than 60 projects under research, has obtained more than 160 registration certificates and more than 30 invention patents.
After the establishment of its R&D Center, it has successively undertaken a dozen of major science and technology projects commissioned by the Changsha Municipal Commission of Science and Technology, the Ministry of Science and Technology and the National Development and Reform Commission. Its R&D organizations and forces include Changsha Enterprise Technology Center, Hunan Technology Center, POCT Engineering Technology Center, as well as a powerful R&D team of more than 50 people, including more than 10 external technical experts. The R&D Center boasts more than 1,200㎡ test site, which is equipped with more than 100 sets of large testing equipment (e.g. Hitachi U3900/3900H ultraviolet spectrophotometer, Basic Power Supply Electrophoresis System, life ELIASA, Sartorius Cross Flow Ultra-filtration Systems, and high speed freezing centrifuge), which can meet the requirements for a range of biological and chemical tests, e.g. immunology, molecule, biochemistry, and fermentation.
The Company attaches great importance to university-industry cooperation. It has established a strategic relationship with many organizations, including XiangYa School of Medicine, Hunan University and Hunan Testing Institute for Medical Devices. In recent years, it has undertaken many ministerial and provincial-level R&D projects jointly with these organizations, to solve the technical problems encountered in the industry, advanced the advanced detection technology to apply in the prevention and treatment of serious illnesses, including neurological, tumor, cardiovascular and cerebrovascular diseases and chronic diseases, and promoted these technologies to be popularized and benefit the people.